| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 3.4K | 7.2% |
| Total Income | 3.5K | 6.6% |
| Expenditure | 2.7K | 5.0% |
| PBT | 771.01 | 94.5% |
| Net Profit | 667.91 | 107.2% |
| OPM | 22.31% | 9.86pp |
| NPM | 19.04% | 9.24pp |
| EPS | 55.56 | 117.3% |
Alkem Laboratories Ltd Announces Q1 2025 Financial Results with 33,711.4 Million Revenue
12 Aug 2025 · 12 Aug 2025, 01:29 pm
Summary
Alkem Laboratories Ltd has announced its Q1 2025 financial results with a revenue of 33,711.4 Million. The board of directors approved the standalone and consolidated unaudited financial results for the quarter ended 30 June, 2025.
Key Highlights
- 1
Q1 2025 revenue stands at 33,711.4 Million
- 2
The board approved the standalone and consolidated unaudited financial results for the quarter ended 30 June, 2025
Management Comments
M
Manish Narang
This information is also available on the website of the Company at www.alkemlabs.com Kindly take the same on record.
Informational and educational content only. Not investment advice.